399 related articles for article (PubMed ID: 28123893)
1. CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside.
Zhang Q; Zhang Z; Peng M; Fu S; Xue Z; Zhang R
Oncoimmunology; 2016; 5(12):e1251539. PubMed ID: 28123893
[TBL] [Abstract][Full Text] [Related]
2. Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325
[TBL] [Abstract][Full Text] [Related]
3. Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells.
Yazdanifar M; Zhou R; Mukherjee P
Curr Trends Immunol; 2016; 17():95-115. PubMed ID: 28659689
[TBL] [Abstract][Full Text] [Related]
4. Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.
Zhang BL; Qin DY; Mo ZM; Li Y; Wei W; Wang YS; Wang W; Wei YQ
Sci China Life Sci; 2016 Apr; 59(4):340-8. PubMed ID: 26965525
[TBL] [Abstract][Full Text] [Related]
5. Improved survival of chimeric antigen receptor-engineered T (CAR-T) and tumor-specific T cells caused by anti-programmed cell death protein 1 single-chain variable fragment-producing CAR-T cells.
Nakajima M; Sakoda Y; Adachi K; Nagano H; Tamada K
Cancer Sci; 2019 Oct; 110(10):3079-3088. PubMed ID: 31432594
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies.
Kiesgen S; Chicaybam L; Chintala NK; Adusumilli PS
J Thorac Oncol; 2018 Jan; 13(1):16-26. PubMed ID: 29107016
[TBL] [Abstract][Full Text] [Related]
7. Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future.
Srour SA; Akin S
J Immunother Precis Oncol; 2023 Feb; 6(1):19-30. PubMed ID: 36751657
[TBL] [Abstract][Full Text] [Related]
8. CAR designs for solid tumors: overcoming hurdles and paving the way for effective immunotherapy.
Cui Y; Luo M; Gu C; He Y; Yao Y; Li P
Biophys Rep; 2023 Oct; 9(5):279-297. PubMed ID: 38516299
[TBL] [Abstract][Full Text] [Related]
9. Chimeric Antigen Receptor beyond CAR-T Cells.
Qin VM; D'Souza C; Neeson PJ; Zhu JJ
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499101
[TBL] [Abstract][Full Text] [Related]
10. Chimeric Antigen Receptor T Cell Based Immunotherapy for Cancer.
Li F; Zhang T; Cao L; Zhang Y
Curr Stem Cell Res Ther; 2018; 13(5):327-335. PubMed ID: 29676233
[TBL] [Abstract][Full Text] [Related]
11. Chimeric antigen receptor-natural killer cells: Novel insight into immunotherapy for solid tumors (Review).
Peng X; Chen L; Chen L; Wang B; Wang Y; Zhan X
Exp Ther Med; 2021 Apr; 21(4):340. PubMed ID: 33732313
[TBL] [Abstract][Full Text] [Related]
12. Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.
Mirzaei HR; Rodriguez A; Shepphird J; Brown CE; Badie B
Front Immunol; 2017; 8():1850. PubMed ID: 29312333
[TBL] [Abstract][Full Text] [Related]
13. Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions.
Bagley SJ; O'Rourke DM
Pharmacol Ther; 2020 Jan; 205():107419. PubMed ID: 31629009
[TBL] [Abstract][Full Text] [Related]
14. Chimeric antigen receptor modified T-cells for cancer treatment.
Han X; Wang Y; Han WD
Chronic Dis Transl Med; 2018 Dec; 4(4):225-243. PubMed ID: 30603741
[TBL] [Abstract][Full Text] [Related]
15. Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment.
Zhao Z; Xiao X; Saw PE; Wu W; Huang H; Chen J; Nie Y
Sci China Life Sci; 2020 Feb; 63(2):180-205. PubMed ID: 31883066
[TBL] [Abstract][Full Text] [Related]
16. CAR T Cell Therapy for Solid Tumors.
Newick K; O'Brien S; Moon E; Albelda SM
Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544
[TBL] [Abstract][Full Text] [Related]
17. Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma.
Chmielewski M; Hombach AA; Abken H
Immunol Rev; 2014 Jan; 257(1):83-90. PubMed ID: 24329791
[TBL] [Abstract][Full Text] [Related]
18. Chimeric antigen receptor transduced T cells: Tuning up for the next generation.
Schubert ML; Hoffmann JM; Dreger P; Müller-Tidow C; Schmitt M
Int J Cancer; 2018 May; 142(9):1738-1747. PubMed ID: 29119551
[TBL] [Abstract][Full Text] [Related]
19. Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors.
Boccalatte F; Mina R; Aroldi A; Leone S; Suryadevara CM; Placantonakis DG; Bruno B
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291891
[TBL] [Abstract][Full Text] [Related]
20. T-cell receptor and chimeric antigen receptor in solid cancers: current landscape, preclinical data and insight into future developments.
Azizi AA; Pillai M; Thistlethwaite FC
Curr Opin Oncol; 2019 Sep; 31(5):430-438. PubMed ID: 31335828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
